Innovis Asset Management LLC Tarsus Pharmaceuticals, Inc. Transaction History

Innovis Asset Management LLC

  • $260 Billion
  • Q3 2023

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 03, 2023
BUY
$11.57 - $19.63 $948 - $1,609
82 Added 0.63%
13,141 $237 Million
Q1 2023

May 10, 2023
BUY
$11.92 - $16.27 $929 - $1,269
78 Added 0.6%
13,059 $164 Million
Q4 2022

Feb 14, 2023
BUY
$14.12 - $18.72 $183,291 - $243,004
12,981 New
12,981 $190 Million

Others Institutions Holding TARS

# of Institutions
173
Shares Held
43.6M
Call Options Held
484K
Put Options Held
4.1K
View Full List

About Tarsus Pharmaceuticals, Inc.

TARS Quotes by TradingView
  • Ticker TARS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,658,500
  • Market Cap $1.31B
  • Description
  • Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as...
More about TARS
Track This Portfolio

Track Innovis Asset Management LLC Portfolio

Follow Innovis Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Innovis Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Innovis Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email